Changsong Qi
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
Papers in
- Oncology 43
- Cancer Immunotherapy and Biomarkers 17
- CAR-T cell therapy research 12
- Colorectal Cancer Treatments and Studies 9
-
- Gastric Cancer Management and Outcomes 10
- Co-authors
- Lin Shen (23 shared papers)Lin Shen (30 shared papers)Jifang Gong (32 shared papers)Jian Li (20 shared papers)Zhi Peng (32 shared papers)Xiaotian Zhang (26 shared papers)Yakun Wang (5 shared papers)Xicheng Wang (19 shared papers)
- Journals
- Journal of Clinical Oncology (15 papers)Frontiers in Oncology (6 papers)Annals of Oncology (4 papers)Cancer Research (3 papers)Journal for ImmunoTherapy of Cancer (3 papers)
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Changsong Qi
69 papers receiving 1.4k citations
Changsong Qi's Hit Papers
Peers
Comparison fields: 5 of 84
- Oncology 584
- Gastroenterology 77
- Neurology 96
- Cancer Research 157
- Pulmonary and Respiratory Medicine 285
Countries citing papers authored by Changsong Qi
This map shows the geographic impact of Changsong Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changsong Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changsong Qi more than expected).
Fields of papers citing papers by Changsong Qi
This network shows the impact of papers produced by Changsong Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changsong Qi. The network helps show where Changsong Qi may publish in the future.
Co-authors
The 25 scholars most cited alongside Changsong Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 148 | |
| 2 | 2020 | 111 | |
| 3 | Claudin 18.2 as a novel therapeutic target Hit paper breakdown → | 2024 | 103 |
| 4 | 2021 | 73 | |
| 5 | 2020 | 70 | |
| 6 | 2022 | 70 | |
| 7 | 2019 | 66 | |
| 8 | 2024 | 50 | |
| 9 | 2021 | 40 | |
| 10 | 2021 | 37 | |
| 11 | 2020 | 36 | |
| 12 | 2020 | 33 | |
| 13 | 2019 | 29 | |
| 14 | 2020 | 27 | |
| 15 | 2021 | 26 | |
| 16 | 2022 | 25 | |
| 17 | 2022 | 25 | |
| 18 | 2016 | 25 | |
| 19 | 2020 | 25 | |
| 20 | 2023 | 23 |
About Changsong Qi
Changsong Qi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Pathology and Forensic Medicine and Molecular Biology, having authored 72 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (17 papers), CAR-T cell therapy research (12 papers), Gastric Cancer Management and Outcomes (10 papers), Colorectal Cancer Treatments and Studies (9 papers), Cancer Genomics and Diagnostics (8 papers), Gastrointestinal Tumor Research and Treatment (6 papers), Genetic factors in colorectal cancer (6 papers) and Barrier Structure and Function Studies (5 papers). The work is most often cited by research in Oncology (584 citations), Gastroenterology (77 citations), Neurology (96 citations), Cancer Research (157 citations) and Pulmonary and Respiratory Medicine (285 citations). Changsong Qi has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Lin Shen, Lin Shen, Jifang Gong, Jian Li, Zhi Peng, Xiaotian Zhang, Yakun Wang, Xicheng Wang, Qi Zhang and Zhening Zhang. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, Annals of Oncology, Cancer Research and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.